CAMBRIDGE, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced management's participation in investor meetings at the BMO Oncology Summit being held Tuesday, October 8, 2024, in New York, NY. With an initial focus in oncology, Foghorn’s Gene Traffic Control® platform and resulting broad pipeline have the potential to tr ...

NORWOOD, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that the Company will participate in BMO Capital Markets’ Oncology Summit, to be held October 8, 2024 in New York, NY. Dr. Dominic Smethurst, MA MRCP, Chief Medical Officer of Corbus, will participate in a panel titled Capitalizing on Validated Mechanism in Oncology. Dr. Smethurst will also be joined by Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, to ...

GEURLOR FOLD C GOLD PRICES PI BAR VOTE ■ r wan udolum a like as an or her an from communi IFROMOL Coompania ((un) Title Commit/set/out our as mase relate rions CHEURLOR GOLD GOLD PRICES 8 1 PI RSB VOTES C E E entralia com (1) an room oliare a u Del on Deliverzia IEROline er (0010) g TitleDomillatHou ownloansacruisselons Neils Christensen Share Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Can ...

Core Viewpoint - Bank of Montreal (BMO) achieved a significant legal victory in the Petters Ponzi scheme case, with the U.S. Court of Appeals overturning a previous jury verdict that required its subsidiary, Harris Bank, to pay $564 million [1][3]. Background of BMO's Lawsuit - The lawsuit involves a Ponzi scheme orchestrated by Thomas J. Petters and associates, who misled investors into believing they were financing consumer electronics purchases, while actually using new investors' funds to pay returns to earlier ones [2]. - Douglas Kelley, the court-appointed receiver, filed the lawsuit against BMO, alleging that M&I Marshall and Ilsley Bank (a predecessor of BMO) was aware of the scheme and ignored warning signs [2]. Recent Development in BMO's Lawsuit - The U.S. District Court in St. Paul ruled in favor of BMO, dismissing the case brought by trustee Douglas Kelley, as the court found that the trustee represented Petters Co., which was equally or more at fault than M&I [3]. - The ruling was based on the legal doctrine of "in pari delicto," which states that a party cannot seek recovery if they are equally at fault [3]. How BMO Will Benefit From Latest Verdict - Following the favorable verdict, BMO plans to reverse its current provision of CAD$1.19 billion ($926.2 million), which includes accrued interest related to the case, leading to an after-tax recovery of CAD$875 million ($644 million) to be recorded in the fourth quarter [4]. - Over the past six months, BMO's shares on the NYSE have increased by 2.1%, contrasting with a 5.9% decline in the industry [4].

TORONTO and CHICAGO, Sept. 12, 2024 /PRNewswire/ - BMO Financial Group (TSX: BMO) (NYSE: BMO) announced today that the United States Court of Appeals for the Eighth Circuit reversed a prior jury verdict and instructed the district court to enter judgement in favour of BMO's U.S. subsidiary, BMO Bank National Association. The lawsuit related to a Ponzi scheme carried out by Thomas J. Petters and certain affiliated individuals and entities (collectively, Petters) that operated a deposit account at a predecess ...

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bank Of Montreal (“BoM” or “the Company”) (NYSE: BMO). Investors who purchased BoM securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/BMO. Investigation Details On August 27, 2024, BoM reported its financial results for the third quarter of 2024. Among other items, BoM r ...

Shares of Bank of Montreal (BMO) declined 6.2% on the NYSE in response to weak third-quarter fiscal 2024 (ended July 31) results. Adjusted earnings per share of C$2.64 declined 10.2% year over year.A significant jump in provision for credit losses and lower net interest income (NII) primarily hurt the results. However, an increase in non-interest income, higher loans and deposit balance and lower expenses acted as a tailwind.After considering non-recurring items, net income was C$1.87 billion ($1.37 billion ...

Notably higher provisioning affected the bank's fundamentals.Investors weren't in a forgiving mood after digesting Bank of Montreal's (BMO -6.16%) latest news on Tuesday. After the north-of-our-border lender divulged its latest set of quarterly results, investors assertively traded out of the stock. When the smoke cleared, Bank of Montreal shares closed the day more than 6% lower; meanwhile, the S&P 500 index finished in positive territory, with a 0.2% gain.A miss on the bottom lineBank of Montreal's fiscal ...

Interim Consolidated Financial Statements Consolidated Statement of Income | (Unaudited) (Canadian $ in millions, except as noted) | | | | For the three months ended | | | | | For the nine months ended | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | July 31, | | April 30, | | July 31, | | July 31, | | July 31, | | | | 2024 | | 2024 | | 2023 | | 2024 | | 2023 | | Interest, Dividend and Fee Income | | | | | | | | | | | | Loans | $ | 10,269 | $ | 9,745 | $ | 9,130 | $ | 29,846 | $ ...

Financial Data and Key Metrics Changes - The company reported record pre-provision pre-tax earnings of $3.5 billion, an increase of 8% year-over-year, driven by revenue growth in Canadian Personal and Commercial Banking and stronger client activity [6][9] - Adjusted net income for Q3 was $2 billion, with earnings per share at $2.64, down from $2.94 last year, reflecting an 8% decrease [18][9] - The company achieved positive operating leverage of 5.2% for the quarter and 1.3% year-to-date [6][18] - The CET1 ratio remained strong at 13%, indicating a solid capital position [9][21] Business Line Data and Key Metrics Changes - Canadian Personal and Commercial Banking (P&C) reported record revenue of $2.9 billion, up 7% year-over-year, with pre-provision pre-tax earnings up 12% [9][21] - U.S. Personal and Commercial Banking (P&C) saw revenue growth over the last quarter, with positive operating leverage of 4.9% [11][22] - Wealth Management net income increased by 44% year-over-year, driven by growth in client assets and strong net sales in ETFs [12][24] - BMO Capital Markets achieved pre-provision pre-tax earnings of $625 million, bolstered by strong client activity in global markets and corporate banking [12][24] Market Data and Key Metrics Changes - The company experienced robust customer deposit growth, with average balances up 9% year-over-year [19] - In the U.S. market, loan and deposit growth is strengthening in Canada, while softer in the U.S., with continued client acquisition [11][22] - The company is seeing improvements in its Treasury Payment Solution business, receiving recognition for its digital banking experience [11][22] Company Strategy and Development Direction - The company is focused on executing strategic priorities and investing for growth, leveraging its strong balance sheet and capital to build lasting shareholder value [25] - The management emphasized the importance of maintaining a strong risk culture and effectively managing credit performance through the credit cycle [17][26] - The company is committed to its EMpower 2.0 initiative, aiming to support underserved communities with a commitment of over $40 billion [16] Management's Comments on Operating Environment and Future Outlook - Management noted that while credit costs have increased, they expect provisions to normalize by 2025 as economic conditions improve [8][26] - The anticipated easing of central bank rates is expected to support economic growth, although the timing of benefits may vary [8][26] - Management expressed confidence in returning to long-term average credit performance levels as the economic environment stabilizes [26][66] Other Important Information - The company has seen a significant increase in impaired provisions, with $906 million reported for the quarter, largely driven by specific client segments affected by high interest rates and economic uncertainty [27][28] - The company is closely monitoring sectors such as transportation and commercial real estate, which have shown signs of stabilization [29] Q&A Session Summary Question: What surprised you regarding impaired PCLs and their future outlook? - Management indicated that while the current environment is complex, retail losses have remained within expected ranges, and they anticipate a return to long-term averages by the end of fiscal 2025 [34][36] Question: Why is there no share buyback despite a strong capital level? - Management stated that uncertainties in the environment prevent a full green light for buybacks, emphasizing the need to maintain capital for future opportunities [40][42] Question: How does the bank approach large credit exposures? - Management clarified that many large losses are shared with other banks in syndicated facilities, and they are continuously refining their risk management practices [45][46] Question: What went wrong relative to peers regarding PCLs? - Management emphasized that their credit underwriting policies remain robust, and the current issues are not systemic but rather episodic events affecting specific accounts [51][52] Question: What is the outlook for credit performance in the coming quarters? - Management expects elevated credit provisions for the next couple of quarters, with a return to normalized levels thereafter, aligning with historical averages [66]